Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
FM 140 vs FM100 Study in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan and Fludarabine in Patients With AML and MDS
- Status
- COMPLETED
- Phase
- PHASE2
Cord Blood Expansion on Mesenchymal Stem Cells
- Status
- COMPLETED
- Phase
- PHASE1
Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders
- Status
- TERMINATED
- Phase
- PHASE2
Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
- Status
- UNKNOWN
- Phase
- PHASE2
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3